Weekly Recap: Nasdaq compliance regained and leadership, audit oversight changes
Valion Bio, Inc. (NASDAQ:VBIO) said Nasdaq closed its noncompliance case after VBIO kept its share price above $1.00, and announced leadership changes—Dean Zikria as interim CEO, Thomas Jensen as board chair and Jared Malbin as audit chair—as Sheryle Bolton departed the board.Previous Week RecapThi…